Question 1

What does Juno Therapeutics do?

Accepted Answer

Juno Therapeutics is a clinical-stage company, develops immunotherapies for the treatment of cancer.

Question 2

In what sectors does Juno Therapeutics operate?

Accepted Answer

Juno Therapeutics operates in Biotechnology, Clinical Trials, Health Care, Medical, Oncology.

Question 3

How many companies has Juno Therapeutics acquired?

Accepted Answer

Juno Therapeutics has made 5 acquisitions between 2015-2016, with a total disclosed deal value of $191.0M.

Question 4

How many acquisitions does Juno Therapeutics make in a year?

Accepted Answer

Over the last 5 years, Juno Therapeutics has made about 1 acquisitions per year.

Question 5

What companies are owned by Juno Therapeutics?

Accepted Answer

Companies acquired by Juno Therapeutics include RedoxTherapies, Contura, AbVitro, X BODY, Stage Cell Therapeutics.

Question 6

What are Juno Therapeutics's major acquisitions?

Accepted Answer

Juno Therapeutics's largest acquisitions include AbVitro ($125.0M, 2016), X BODY ($44.0M, 2015), Stage Cell Therapeutics ($22.0M, 2015).

Question 7

What is Juno Therapeutics's largest acquisition?

Accepted Answer

Juno Therapeutics's largest disclosed acquisition is AbVitro for $125.0M (2016).

Question 8

What was Juno Therapeutics's first acquisition?

Accepted Answer

Juno Therapeutics's first recorded acquisition was Stage Cell Therapeutics in 2015 for $22.0M.

Question 9

What was Juno Therapeutics's most recent acquisition?

Accepted Answer

Juno Therapeutics's most recent acquisition is RedoxTherapies, announced July 2016.

Question 10

What is the average deal size for Juno Therapeutics acquisitions?

Accepted Answer

The average disclosed deal size for Juno Therapeutics acquisitions is $63.7M.

Question 11

What is the median deal size for Juno Therapeutics acquisitions?

Accepted Answer

The median disclosed deal size for Juno Therapeutics acquisitions is $44.0M. The median is often lower than the average because a few very large deals pull the average up.

Question 12

How much has Juno Therapeutics spent on acquisitions?

Accepted Answer

Juno Therapeutics has spent at least $191.0M across its disclosed acquisitions (of 5 total deals; some prices are undisclosed).

Question 13

Which sector has Juno Therapeutics spent the most on?

Accepted Answer

Juno Therapeutics has committed the most disclosed capital to Biotechnology companies — about $191.0M across its deals in that sector.

Question 14

What sectors does Juno Therapeutics usually acquire in?

Accepted Answer

Juno Therapeutics most frequently acquires companies in Biotechnology, Medical, Therapeutics.

Question 15

In which sector has Juno Therapeutics made the most acquisitions?

Accepted Answer

Juno Therapeutics has made the most acquisitions in the Biotechnology sector.

Question 16

In which year did Juno Therapeutics make the most acquisitions?

Accepted Answer

Juno Therapeutics made the most acquisitions in 2016, with 3 deals.

Datasets

Top Companies

Top Industries

Years (1990-2026)

Juno Therapeutics

Company Details

Funding & Financials

Web Traffic

Technology & IP

Investor Activity

Company Info

Signals & Scores

Investments by Juno Therapeutics

Acquisitions by Juno Therapeutics

Key People at Juno Therapeutics

Explore 200,000+ acquisitions — free

Recent News related to Juno Therapeutics

FAQs about Juno Therapeutics

People who checked this page also checked these